Asset Management One Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Asset Management One Co., Ltd.

  • $27.7 Billion
  • Q3 2024

A detailed history of Asset Management One Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 56,476 shares of REGN stock, worth $40.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
56,476
Previous 55,263 2.19%
Holding current value
$40.2 Million
Previous $58.1 Million 2.21%
% of portfolio
0.21%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$1024.09 - $1201.76 $1.24 Million - $1.46 Million
1,213 Added 2.19%
56,476 $59.4 Million
Q2 2024

Jul 18, 2024
SELL
$883.2 - $1071.19 $402,739 - $488,462
-456 Reduced 0.82%
55,263 $58.1 Million
Q1 2024

May 02, 2024
BUY
$902.69 - $993.35 $202,202 - $222,510
224 Added 0.4%
55,719 $53.6 Million
Q4 2023

Jan 24, 2024
BUY
$775.18 - $881.7 $2.4 Million - $2.73 Million
3,095 Added 5.91%
55,495 $48.7 Million
Q3 2023

Oct 19, 2023
BUY
$692.45 - $844.37 $188,346 - $229,668
272 Added 0.52%
52,400 $43.1 Million
Q2 2023

Jul 31, 2023
SELL
$700.03 - $830.35 $165,907 - $196,792
-237 Reduced 0.45%
52,128 $37.5 Million
Q1 2023

Apr 25, 2023
BUY
$680.49 - $826.97 $524,657 - $637,593
771 Added 1.49%
52,365 $43 Million
Q4 2022

Feb 06, 2023
SELL
$705.89 - $766.39 $2.57 Million - $2.79 Million
-3,645 Reduced 6.6%
51,594 $37.2 Million
Q3 2022

Nov 04, 2022
SELL
$573.97 - $724.32 $1.02 Million - $1.28 Million
-1,772 Reduced 3.11%
55,239 $38.1 Million
Q2 2022

Jul 29, 2022
SELL
$548.35 - $738.84 $1.85 Million - $2.5 Million
-3,380 Reduced 5.6%
57,011 $33.7 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $87,482 - $102,669
-147 Reduced 0.24%
60,391 $42.2 Million
Q4 2021

Feb 09, 2022
SELL
$543.48 - $670.97 $1.57 Million - $1.93 Million
-2,883 Reduced 4.55%
60,538 $39.2 Million
Q3 2021

Nov 02, 2021
SELL
$574.03 - $680.96 $758,867 - $900,229
-1,322 Reduced 2.04%
63,421 $38.4 Million
Q2 2021

Aug 03, 2021
BUY
$472.8 - $558.54 $701,162 - $828,314
1,483 Added 2.34%
64,743 $36.2 Million
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $150,548 - $184,743
-337 Reduced 0.53%
63,260 $29.9 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $907,335 - $1.15 Million
-1,897 Reduced 2.9%
63,597 $30.8 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $3.06 Million - $3.69 Million
5,611 Added 9.37%
65,494 $36.7 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $8.64 Million - $11.3 Million
17,519 Added 41.35%
59,883 $37.3 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $7,732 - $11,371
23 Added 0.05%
42,364 $20.7 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $585,541 - $804,225
-2,136 Reduced 4.8%
42,341 $15.9 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $22,423 - $26,107
82 Added 0.18%
44,477 $12.3 Million
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $2.62 Million - $3.63 Million
-8,748 Reduced 16.46%
44,395 $13.9 Million
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $29.5 Million - $34.9 Million
-79,331 Reduced 59.88%
53,143 $21.8 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $1.32 Million - $1.59 Million
3,934 Added 3.06%
132,474 $49.4 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $168,196 - $195,676
479 Added 0.37%
128,540 $52 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $1.9 Million - $2.3 Million
6,668 Added 5.49%
128,061 $44.1 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $74,217 - $92,538
-235 Reduced 0.19%
121,393 $41.8 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $208,005 - $272,571
580 Added 0.48%
121,628 $45.8 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $123,806 - $144,648
287 Added 0.24%
121,048 $54.1 Million
Q2 2017

Aug 14, 2017
BUY
N/A
120,761
120,761 $59.4 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email